Vascular Lesion Treatment Laser Market Report 2025

The vascular lesion treatment laser market size has grown rapidly in recent years. It will grow from $1.64 billion in 2024 to $1.83 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth during the historic period was driven by the increasing prevalence of vascular lesions due to aging populations, growing awareness of cosmetic and aesthetic treatments, rising adoption of minimally invasive laser therapies, expansion of dermatology clinics and specialty centers, and the growing influence of medical tourism in emerging economies.

The vascular lesion treatment laser market size is expected to see rapid growth in the next few years. It will grow to $2.75 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth during the forecast period is fueled by rising demand for non-invasive and pain-free treatment options, wider availability of multi-application laser platforms, expansion of healthcare infrastructure in developing countries, growing preference for laser therapy over traditional surgery, and increased focus on personalized and targeted aesthetic treatments. The primary trends in the forecast period include development of artificial intelligence powered laser treatment platforms, creation of user-friendly interfaces for dermatologists and clinics, integration of laser systems with imaging and diagnostic tools, incorporation of robotics and automation in laser procedures, and innovation in multi-wavelength laser platforms for greater versatility.

The rising demand for minimally invasive procedures is expected to drive growth in the vascular lesion treatment laser market. These procedures are performed through small incisions or natural body openings, resulting in less tissue damage, quicker recovery times, and fewer complications compared to traditional surgeries. The appeal of minimally invasive methods lies in their ability to reduce pain, shorten hospital stays, and enable patients to return to their normal activities faster than with conventional surgeries. Vascular lesion treatment lasers enhance the benefits of these procedures by precisely targeting abnormal blood vessels, minimizing tissue damage, and promoting quicker recovery with less scarring. According to the American Society of Plastic Surgeons in June 2024, minimally invasive procedures saw a 7% increase in 2023, outpacing the growth of traditional surgeries by 2%. This surge in demand is a key factor driving the expansion of the vascular lesion treatment laser market.

Companies in the vascular lesion treatment laser market are increasingly focusing on developing advanced solutions, such as dual-wavelength laser platforms, to improve treatment precision and patient comfort. These platforms combine two laser wavelengths in one system, allowing for more effective targeting of various vascular lesions while minimizing damage to surrounding tissue. For example, in April 2025, Candela Medical Inc., a US-based medical device company, introduced the Vbeam Pro laser platform, which integrates a 595 nm pulsed dye laser and a 1064 nm Nd:YAG wavelength. This dual-wavelength system is FDA-cleared for use in pediatric patients and offers greater precision and versatility for treating a range of vascular and dermatologic conditions, such as rosacea, port-wine stains, acne, and spider veins. The system also improves lesion clearance by 20%, reduces treatment times by 50%, and cuts patient discomfort by 20%, marking a significant advancement in pulsed dye laser technology.

In June 2023, Hahn and Company, a private equity firm based in South Korea, acquired Lutronic, a company specializing in advanced laser systems for treating vascular lesions. This acquisition strengthens Hahn and Company’s presence in the medical aesthetics market, leveraging Lutronic's innovative technologies and global reach to expand their offerings in this field.

Major players in the vascular lesion treatment laser market are El.En. S.p.A., Lumenis Ltd., Candela Corporation, Alma Lasers Ltd., DEKA M.E.L.A. S.r.l., Venus Concept Inc., Fotona d.o.o., Sciton Inc., Sensus Healthcare Inc., Biolitec AG, Wuhan Gigaa Optronics Technology Co. Ltd., SharpLight Technologies Ltd., Beijing Nubway S And T Co. Ltd., Aerolase Inc., Astanza Laser LLC, Lynton Lasers Ltd., Asclepion Laser Technologies GmbH, Quanta System S.p.A., Beijing Sincoheren S And T Development Co. Ltd., Nanjing Bestview Laser Co. Ltd.

North America was the largest region in the vascular lesion treatment laser market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vascular lesion treatment laser report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the vascular lesion treatment laser market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A vascular lesion treatment laser is a specialized medical laser system designed to target and treat abnormal or visible blood vessels, such as spider veins, hemangiomas, or port-wine stains, by delivering focused light energy. The laser selectively heats and collapses the blood vessels without damaging surrounding skin, resulting in clearer and healthier looking tissue.

The primary types of vascular lesion treatment lasers include telangiectasia, hemangiomas, varicose veins, and port wine stains. Telangiectasia refers to small, widened blood vessels visible on the skin’s surface, which can be treated with lasers to reduce redness and visible veins. Treatment technologies include pulsed dye lasers, neodymium-doped yttrium aluminum garnet lasers, intense pulsed light, diode lasers, and erbium lasers. These lasers are applied in areas such as aesthetic procedures, medical treatments, cosmetic enhancements, skin resurfacing, and tattoo removal. End users include hospitals, dermatology clinics, cosmetic surgery centers, ambulatory surgical centers, and home care settings.

The vascular lesion treatment laser market research report is one of a series of new reports that provides vascular lesion treatment laser market statistics, including vascular lesion treatment laser industry global market size, regional shares, competitors with a vascular lesion treatment laser market share, detailed vascular lesion treatment laser market segments, market trends and opportunities, and any further data you may need to thrive in the vascular lesion treatment laser industry. This vascular lesion treatment laser market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular lesion treatment laser market consists of revenues earned by entities by providing services such as spider vein removal, port-wine stain treatment, hemangioma treatment, rosacea management, telangiectasia treatment, and leg vein therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular lesion treatment laser market also includes sales of alexandrite lasers, krypton lasers, argon lasers, copper vapor lasers, and ruby lasers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.